Earlier-Life Predictors of Midlife Risk Factors for Dementia: A 35-Year Follow-up

中年痴呆症风险因素的早期预测因素:35 年随访

基本信息

  • 批准号:
    10596295
  • 负责人:
  • 金额:
    $ 130.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-03-01 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

Alzheimer’s disease (AD) and related dementias (AD/ADRD) are a public health crisis in the US marked by growing racial disparities, with African Americans (AAs) two to three times more likely to be diagnosed than non-Hispanic Whites. Efforts to identify modifiable earlier-life risk and protective factors for known midlife risk factors for poor cognitive outcomes in later life are needed to protect the health of middle-aged and older AAs. We propose to prospectively examine trajectories of stress exposures from childhood to early midlife as predictors of known midlife risk factors for subsequent AD/ADRD in two primarily (~66%) AA cohorts that are now ages 41-45 and have been followed repeatedly from age 6 to age 32 (2009-2011) by the Johns Hopkins Prevention Intervention Research Center (PIRC). Relevant individual- and community- level stress exposures that occur from early life to middle adulthood include: 1) adverse life circumstances (i.e., extreme poverty, residential instability, crime, incarceration, racial discrimination, traumatic events); 2) mental disorders and their symptoms; and 3) poor sleep (e.g., abnormal duration, fragmentation). Additionally, these stress exposures have been linked to other risk factors for AD/ADRD, including obesity, hypertension, and diabetes, by which AAs are disproportionately affected. We aim to determine the extent to which ~35-year trajectories of stress exposures are associated with estimated midlife risk for later-life AD/ADRD, physiological aging (telomere length, p16, methylation age), epigenetic modification, and inflammation, and cognitive performance—all measured in early midlife—and if these associations are moderated by sex, race, and AD/ADRD risk genes. We will also explore how the timing of exposures in the life-course affects these associations, and if other potential moderators (e.g., childhood academic achievement, educational/occupational attainment, alcohol/drug use, conduct problems, social support, perceived control) affect these associations. We will further explore effects of two early-life (ages 6-8) PIRC interventions on midlife study outcomes. To accomplish this, 1,150 PIRC participants will complete two in- home interviews including a cognitive battery and actigraphic sleep assessments, and we will collect biospecimens for genetic and epigenetic material and physiological aging measures. This study is a rare opportunity to clarify links of earlier-life stress exposures with estimated midlife dementia risk, identify vulnerable subgroups for targeted AD/ADRD prevention, elucidate the role of social inequities in determining racial disparities in AD dementia, and establish a midlife cognitive baseline for future follow-up of these unusually well-characterized longitudinal, primarily AA cohorts.
阿尔茨海默病(AD)和相关痴呆症(AD/ADRD)是美国的一种公共卫生危机, 种族差异日益扩大,非裔美国人(AA)被诊断出的可能性是普通人的两到三倍 非西班牙裔白人努力确定已知中年的可改变的早期生活风险和保护因素 老年人认知能力差的风险因素是保护中年人健康所必需的, 年长的AA我们建议前瞻性地研究从童年到早期的压力暴露轨迹 在两个主要(约66%)AA中,中年作为随后AD/ADRD的已知中年风险因素的预测因子 现在年龄在41-45岁之间的队列,从6岁到32岁(2009-2011年), 约翰霍普金斯预防干预研究中心(PIRC)。相关个人和社区- 从生命早期到成年中期的水平压力暴露包括:1)不利的生活环境 (i.e.,赤贫、居住不稳定、犯罪、监禁、种族歧视、创伤事件); 2) 精神障碍及其症状;以及3)睡眠不佳(例如,异常持续时间、碎片化)。 此外,这些压力暴露与AD/ADRD的其他风险因素有关,包括肥胖, 高血压和糖尿病,其中AA受到不成比例的影响。我们的目标是确定 其中,约35年的压力暴露轨迹与估计的晚年中年风险相关 AD/ADRD、生理老化(端粒长度、p16、甲基化年龄)、表观遗传修饰和 炎症和认知能力--所有这些都是在中年早期测量的--如果这些关联是 受性别、种族和AD/ADRD风险基因的调节。我们还将探讨如何在曝光的时间, 生命过程影响这些关联,并且如果其他潜在的调节者(例如,儿童学术 成就,教育/职业成就,酒精/药物使用,行为问题,社会支持, 感知控制)影响这些关联。我们将进一步探讨两个早期生命(6-8岁)PIRC的影响, 对中年研究结果的干预。为了实现这一目标,1,150名PIRC参与者将完成两个- 家庭访谈,包括认知电池和活动记录睡眠评估,我们将收集 生物标本的遗传和表观遗传物质和生理老化措施。这项研究是罕见的 有机会澄清早期生活压力暴露与估计的中年痴呆风险之间的联系, 有针对性的AD/ADRD预防的脆弱亚组,阐明社会不平等在以下方面的作用: 确定AD痴呆的种族差异,并为未来的随访建立中年认知基线 这些异常良好的纵向特征,主要是AA队列。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GEORGE W. REBOK其他文献

Effect of Concentration Problems on the Malleability of Children's Aggressive and Shy Behaviors
  • DOI:
    10.1097/00004583-199602000-00013
  • 发表时间:
    1996-02-01
  • 期刊:
  • 影响因子:
  • 作者:
    GEORGE W. REBOK;WESLEY E. HAWKINS;PENELOPE KRENER;LAWRENCE S. MAYER;SHEPPARD G. KELLAM
  • 通讯作者:
    SHEPPARD G. KELLAM

GEORGE W. REBOK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GEORGE W. REBOK', 18)}}的其他基金

The Hopkins Undergraduate Summer Training and Research (USTAR) Program
霍普金斯大学本科生暑期培训与研究 (USTAR) 计划
  • 批准号:
    10420395
  • 财政年份:
    2022
  • 资助金额:
    $ 130.25万
  • 项目类别:
The Hopkins Undergraduate Summer Training and Research (USTAR) Program
霍普金斯大学本科生暑期培训与研究 (USTAR) 计划
  • 批准号:
    10624300
  • 财政年份:
    2022
  • 资助金额:
    $ 130.25万
  • 项目类别:
Earlier-Life Predictors of Midlife Risk Factors for Alzheimer's Disease: A 35-Year Follow-up
阿尔茨海默病中年危险因素的早期预测因素:35 年随访
  • 批准号:
    10460376
  • 财政年份:
    2021
  • 资助金额:
    $ 130.25万
  • 项目类别:
The Johns Hopkins Alzheimer's Disease Resource Center for Minority Aging Research - Admin Core
约翰·霍普金斯大学阿尔茨海默病少数群体老龄化研究资源中心 - 管理核心
  • 批准号:
    10451581
  • 财政年份:
    2018
  • 资助金额:
    $ 130.25万
  • 项目类别:
The Johns Hopkins Alzheimer's Disease Resource Center for Minority Aging Research
约翰·霍普金斯大学阿尔茨海默病少数民族老龄化研究资源中心
  • 批准号:
    9770735
  • 财政年份:
    2018
  • 资助金额:
    $ 130.25万
  • 项目类别:
ACTIVE Cognitive Training Trial: 20-Yr Follow-up of Functioning, Health, & Dementia
主动认知训练试验:20 年功能、健康、
  • 批准号:
    9364519
  • 财政年份:
    2017
  • 资助金额:
    $ 130.25万
  • 项目类别:
ACTIVE Cognitive Training Trial: 20-Yr Follow-up of Functioning, Health, & Dementia
主动认知训练试验:20 年功能、健康、
  • 批准号:
    9754732
  • 财政年份:
    2017
  • 资助金额:
    $ 130.25万
  • 项目类别:
Web-Based ACTIVE Memory Training Intervention for Older Adults
基于网络的老年人主动记忆训练干预
  • 批准号:
    8510887
  • 财政年份:
    2013
  • 资助金额:
    $ 130.25万
  • 项目类别:
Web-Based ACTIVE Memory Training Intervention for Older Adults
基于网络的老年人主动记忆训练干预
  • 批准号:
    8708724
  • 财政年份:
    2013
  • 资助金额:
    $ 130.25万
  • 项目类别:
Experience Corps Trial: Improving Health of Older Populations through Generativit
体验军团试验:通过 Generativit 改善老年人的健康
  • 批准号:
    7931105
  • 财政年份:
    2009
  • 资助金额:
    $ 130.25万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 130.25万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 130.25万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 130.25万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 130.25万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 130.25万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 130.25万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 130.25万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 130.25万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 130.25万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 130.25万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了